 | Up a level |
Greenfield, D M; Salooja, N; Peczynski, C; van der Werf, S; Schoemans, H; Hill, K; Cortelezzi, A; Lupo-Stangellini, M; Özkurt, Z N; Arat, M; Metzner, B; Turlure, P; Rovó, A; Socié, G; Mohty, M; Nagler, A; Kröger, N; Dreger, P; Labopin, M; Han, T S; ... (2021). Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study. Bone marrow transplantation, 56(11), pp. 2820-2825. Springer Nature 10.1038/s41409-021-01414-7
Passweg, J R; Labopin, M; Christopeit, M; Cornelissen, J; Pabst, Thomas; Socié, G; Russel, N; Yakoub-Agha, I; Blaise, D; Gedde-Dahl, T; Labussière-Wallet, H; Malladi, R; Forcade, E; Maury, S; Polge, E; Lanza, F; Gorin, N C; Mohty, M; Nagler, A (2020). Post remission consolidation by autologous HCT for AML in CR1, negative implications for subsequent allogeneic HCT in CR2. A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Biology of blood and marrow transplantation, 26(4), pp. 659-664. Elsevier 10.1016/j.bbmt.2019.11.021
